• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.广泛中和1型人类免疫缺陷病毒抗体基因转移可保护非人灵长类动物免受黏膜猿猴-人类免疫缺陷病毒感染。
J Virol. 2015 Aug;89(16):8334-45. doi: 10.1128/JVI.00908-15.
2
Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.不完全中和活性的广泛中和抗体对恒河猴体内猿猴-人类免疫缺陷病毒的保护效力
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01187-17. Print 2017 Oct 15.
3
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.一种广泛中和HIV-1抗体在体外增强的效力可提高体内抗慢病毒感染的保护作用。
J Virol. 2014 Nov;88(21):12669-82. doi: 10.1128/JVI.02213-14. Epub 2014 Aug 20.
4
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection.在非人灵长类动物中持续递送一种广泛中和抗体可提供针对猿猴/人类免疫缺陷病毒感染的长期保护。
J Virol. 2015 Jun;89(11):5895-903. doi: 10.1128/JVI.00210-15. Epub 2015 Mar 18.
5
Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.以腺相关病毒载体进行抗体基因转移作为预防艾滋病病毒的一种方法。
Immunol Rev. 2017 Jan;275(1):324-333. doi: 10.1111/imr.12478.
6
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.三特异性广泛中和HIV抗体在猕猴中介导对猿猴免疫缺陷病毒的有效保护。
Science. 2017 Oct 6;358(6359):85-90. doi: 10.1126/science.aan8630. Epub 2017 Sep 20.
7
Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.基于中和抗体的细胞相关 HIV-1 感染预防。
Viruses. 2018 Jun 18;10(6):333. doi: 10.3390/v10060333.
8
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.增强的新生儿Fc受体功能可改善对灵长类动物感染猴-人免疫缺陷病毒的保护作用。
Nature. 2014 Oct 30;514(7524):642-5. doi: 10.1038/nature13612. Epub 2014 Aug 13.
9
Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.猕猴体内广泛中和性HIV单克隆抗体的药代动力学和免疫原性
PLoS One. 2015 Mar 25;10(3):e0120451. doi: 10.1371/journal.pone.0120451. eCollection 2015.
10
Vector-Mediated In Vivo Antibody Expression.载体介导的体内抗体表达。
Microbiol Spectr. 2014 Aug;2(4):AID-0016-2014. doi: 10.1128/microbiolspec.AID-0016-2014.

引用本文的文献

1
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.人类免疫缺陷病毒1型疫苗研究的进展与挑战:全面综述
Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148.
2
Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies.改善核酸递送抗体体内表达的结构和序列工程方法。
Mol Ther. 2025 Jan 8;33(1):152-167. doi: 10.1016/j.ymthe.2024.11.030. Epub 2024 Nov 19.
3
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy.HIV广泛中和抗体逃逸能力决定了载体免疫疗法的治疗效果。
bioRxiv. 2024 Jul 13:2024.07.11.603156. doi: 10.1101/2024.07.11.603156.
4
Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects.探索临床前和临床环境中的 HIV 疫苗进展:从历史到未来展望。
Viruses. 2024 Feb 27;16(3):368. doi: 10.3390/v16030368.
5
Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model.非人灵长类动物模型中腺相关病毒载体免疫预防的最新进展
Biomedicines. 2023 Aug 8;11(8):2223. doi: 10.3390/biomedicines11082223.
6
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.针对二聚体包膜表位的寨卡特异性中和抗体。
Cell Rep. 2023 Aug 29;42(8):112942. doi: 10.1016/j.celrep.2023.112942. Epub 2023 Aug 9.
7
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.HIV-1 病毒在 VRC01 抗体介导的预防(AMP)试验中的中和谱。
PLoS Pathog. 2023 Jun 29;19(6):e1011469. doi: 10.1371/journal.ppat.1011469. eCollection 2023 Jun.
8
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.首例人体种系靶向 HIV 纳米颗粒疫苗诱导广泛且针对公众的辅助性 T 细胞反应。
Sci Transl Med. 2023 May 24;15(697):eadf3309. doi: 10.1126/scitranslmed.adf3309.
9
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.使用 AAV9 载体实现高抗体表达和低抗药抗体的策略。
Front Immunol. 2023 Apr 21;14:1105617. doi: 10.3389/fimmu.2023.1105617. eCollection 2023.
10
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a "single-shot" functional cure for HIV infection.腺相关病毒载体递送HIV生物制剂:实现HIV感染“单次注射”功能性治愈的前景。
J Virus Erad. 2023 Feb 17;9(1):100316. doi: 10.1016/j.jve.2023.100316. eCollection 2023 Mar.

本文引用的文献

1
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.慢性HIV-1感染15年期间VRC01抗体谱系的成熟与多样性
Cell. 2015 Apr 23;161(3):470-485. doi: 10.1016/j.cell.2015.03.004. Epub 2015 Apr 9.
2
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection.在非人灵长类动物中持续递送一种广泛中和抗体可提供针对猿猴/人类免疫缺陷病毒感染的长期保护。
J Virol. 2015 Jun;89(11):5895-903. doi: 10.1128/JVI.00210-15. Epub 2015 Mar 18.
3
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.AAV 表达的 eCD4-Ig 提供了对多种 SHIV 挑战的持久保护。
Nature. 2015 Mar 5;519(7541):87-91. doi: 10.1038/nature14264. Epub 2015 Feb 18.
4
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.向猕猴体内被动转移适度滴度的强效且具有广泛中和作用的抗HIV单克隆抗体,可阻断猴免疫缺陷病毒感染。
J Exp Med. 2014 Sep 22;211(10):2061-74. doi: 10.1084/jem.20132494. Epub 2014 Aug 25.
5
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.一种广泛中和HIV-1抗体在体外增强的效力可提高体内抗慢病毒感染的保护作用。
J Virol. 2014 Nov;88(21):12669-82. doi: 10.1128/JVI.02213-14. Epub 2014 Aug 20.
6
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.增强的新生儿Fc受体功能可改善对灵长类动物感染猴-人免疫缺陷病毒的保护作用。
Nature. 2014 Oct 30;514(7524):642-5. doi: 10.1038/nature13612. Epub 2014 Aug 13.
7
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.针对HIV-1包膜的中和抗体在体内的保护作用比针对CD4受体的中和抗体更有效。
Sci Transl Med. 2014 Jul 2;6(243):243ra88. doi: 10.1126/scitranslmed.3008992.
8
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission.载体免疫预防可保护人源化小鼠免受黏膜 HIV 传播。
Nat Med. 2014 Mar;20(3):296-300. doi: 10.1038/nm.3471. Epub 2014 Feb 9.
9
Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.抗体 VRC01 和 10E8 即使在 Ig 框架区大量回复为原始序列的情况下,仍具有广泛和高效的中和 HIV-1 的能力。
J Immunol. 2014 Feb 1;192(3):1100-1106. doi: 10.4049/jimmunol.1302515. Epub 2014 Jan 3.
10
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.慢性HIV-1感染期间广泛中和抗体反应的流行率。
AIDS. 2014 Jan 14;28(2):163-9. doi: 10.1097/QAD.0000000000000106.

广泛中和1型人类免疫缺陷病毒抗体基因转移可保护非人灵长类动物免受黏膜猿猴-人类免疫缺陷病毒感染。

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.

作者信息

Saunders Kevin O, Wang Lingshu, Joyce M Gordon, Yang Zhi-Yong, Balazs Alejandro B, Cheng Cheng, Ko Sung-Youl, Kong Wing-Pui, Rudicell Rebecca S, Georgiev Ivelin S, Duan Lijie, Foulds Kathryn E, Donaldson Mitzi, Xu Ling, Schmidt Stephen D, Todd John-Paul, Baltimore David, Roederer Mario, Haase Ashley T, Kwong Peter D, Rao Srinivas S, Mascola John R, Nabel Gary J

出版信息

J Virol. 2015 Aug;89(16):8334-45. doi: 10.1128/JVI.00908-15.

DOI:10.1128/JVI.00908-15
PMID:26041300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4524228/
Abstract

Broadly neutralizing antibodies (bnAbs) can prevent lentiviral infection in nonhuman primates and may slow the spread of human immunodeficiency virus type 1 (HIV-1). Although protection by passive transfer of human bnAbs has been demonstrated in monkeys, durable expression is essential for its broader use in humans. Gene-based expression of bnAbs provides a potential solution to this problem, although immune responses to the viral vector or to the antibody may limit its durability and efficacy. Here, we delivered an adeno-associated viral vector encoding a simianized form of a CD4bs bnAb, VRC07, and evaluated its immunogenicity and protective efficacy. The expressed antibody circulated in macaques for 16 weeks at levels up to 66 g/ml, although immune suppression with cyclosporine (CsA) was needed to sustain expression. Gene-delivered simian VRC07 protected against simian-human immunodeficiency virus (SHIV) infection in monkeys 5.5 weeks after treatment. Gene transfer of an anti-HIV antibody can therefore protect against infection by viruses that cause AIDS in primates when the host immune responses are controlled.

摘要

广泛中和抗体(bnAbs)可在非人灵长类动物中预防慢病毒感染,并可能减缓人类免疫缺陷病毒1型(HIV-1)的传播。尽管已在猴子中证明通过被动转移人类bnAbs可提供保护,但持久表达对于其在人类中的更广泛应用至关重要。基于基因的bnAbs表达为解决这一问题提供了一种潜在的解决方案,尽管对病毒载体或抗体的免疫反应可能会限制其持久性和疗效。在此,我们递送了一种编码CD4bs bnAb VRC07猿化形式的腺相关病毒载体,并评估了其免疫原性和保护效果。尽管需要用环孢素(CsA)进行免疫抑制以维持表达,但表达的抗体在猕猴体内循环了16周,水平高达66μg/ml。基因递送的猿猴VRC07在治疗后5.5周可保护猴子免受猿猴-人类免疫缺陷病毒(SHIV)感染。因此,当宿主免疫反应得到控制时,抗HIV抗体的基因转移可保护灵长类动物免受导致艾滋病的病毒感染。